| 1554 |
National Cancer Institute |
Html |
en |
Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia. |
| red blood cells | 0.517668 |
| cancer treatment | 0.431205 |
| malignant tumor cells | 0.395015 |
| blood -forming cells | 0.386238 |
| body | 0.377277 |
| PDQ cancer information | 0.428983 |
| clinical trial search | 0.381057 |
| white blood cells | 0.437124 |
| clinical trials | 0.679889 |
| mature blood cells | 0.419721 |
| Natural killer cells | 0.383894 |
| cancer information summary | 0.40184 |
| clinical trial | 0.489229 |
| lymphocytes | 0.390185 |
| Lymphoblastic Leukemia Treatment | 0.406769 |
| Myeloid Leukemia Treatment | 0.391192 |
| blood cells | 0.552101 |
| immature cells | 0.367988 |
| treatment clinical trial | 0.370422 |
| IgVH gene mutation | 0.385864 |
| Cell Leukemia Treatment | 0.388308 |
| NCI PDQ cancer | 0.372246 |
| lymph nodes | 0.416068 |
| Treatment Editorial Board | 0.376334 |
|
| radiation therapy | 0.372299 |
| tyrosine kinase inhibitor | 0.394203 |
| treatment | 0.577005 |
| stored stem cells | 0.374171 |
| myeloid stem cell | 0.372796 |
| immature blood cells | 0.385722 |
| cancer cells | 0.498635 |
| lymphoid stem cell | 0.371902 |
| specific cancer cells | 0.395788 |
| Lymphocytic Leukemia Treatment | 0.392931 |
| treatment clinical trials | 0.392666 |
| Acute Lymphoblastic Leukemia | 0.387556 |
| blood stem cells | 0.421035 |
| National Cancer Institute | 0.439036 |
| normal cells | 0.375452 |
| new treatment | 0.432006 |
| bone marrow | 0.466319 |
| chronic lymphocytic leukemia | 0.905376 |
| cells | 0.56649 |
| cancer clinical trials | 0.397834 |
| cancer | 0.596361 |
| Myelogenous Leukemia Treatment | 0.383031 |
| standard treatment | 0.368392 |
| Leukemia Treatment | 0.421626 |
|
CLICK HERE |
| 1653 |
National Cancer Institute |
Html |
en |
Cancer Genetics Overview (PDQ®)–Health Professional Version |
Expert-reviewed information summary in which the features of hereditary cancer and the structure and content of other PDQ cancer genetics summaries are described. The summary also contains an extensive list of genetics resources available online. |
| risk assessment | 0.737084 |
| germline genetic testing | 0.616915 |
| pathogenic germline variants | 0.607786 |
| genetics cancer risk | 0.586595 |
| germline testing | 0.54014 |
| individual PDQ summaries | 0.545357 |
| common genetic variants | 0.594544 |
| Founder pathogenic variants | 0.555775 |
| Cancer Genetics Risk | 0.634713 |
| tumor sequencing | 0.540563 |
| cancer risk counseling | 0.587676 |
| genetic risk | 0.584149 |
| health care providers | 0.553143 |
| genetic risk assessment | 0.574763 |
| family members | 0.586643 |
| pathogenic variant | 0.712171 |
| cancer predisposition genes | 0.581734 |
| cancer risk assessment | 0.656292 |
| BRCA1/BRCA2 pathogenic variants | 0.580746 |
| rare genetic variants | 0.585466 |
| familial cancer risk | 0.606217 |
| germline pathogenic variant | 0.590911 |
| specific pathogenic variant | 0.581389 |
| genetic cancer susceptibility | 0.617626 |
| genetic sequence testing | 0.55336 |
|
| breast cancer panel | 0.575181 |
| genetic counseling | 0.75599 |
| certain pathogenic variants | 0.569596 |
| cancer susceptibility genes | 0.662603 |
| multigene testing | 0.554102 |
| pathogenic variants | 0.772898 |
| term pathogenic variant | 0.577821 |
| genetic information | 0.615701 |
| predisposition genetic testing | 0.569525 |
| health care | 0.629277 |
| actionable genetic variants | 0.56222 |
| cancer susceptibility | 0.729483 |
| multigene tests | 0.585492 |
| Cancer genetic counseling | 0.65952 |
| breast cancer | 0.623534 |
| cancer predisposition multigene | 0.547293 |
| cancer susceptibility gene | 0.552935 |
| well-characterized cancer susceptibility | 0.539905 |
| genetic variants | 0.628939 |
| prostate cancer | 0.563348 |
| genetic testing | 0.723596 |
| family history | 0.559221 |
| cancer risk | 0.746235 |
| cancer | 0.908258 |
|
CLICK HERE |
| 1696 |
National Cancer Institute |
Html |
en |
Topics in Integrative, Alternative, and Complementary Therapies (PDQ®)–Health Professional Version |
Expert-reviewed information summary that contains information on integrative, complementary, and/or alternative therapies for people with cancer. |
| cancer treatment | 0.500109 |
| standard treatments | 0.546145 |
| National Health Interview | 0.49394 |
| randomized controlled trials | 0.478599 |
| good manufacturing processes | 0.485786 |
| Cancer Complementary | 0.466196 |
| blood cell count | 0.487384 |
| NCI Fact Sheets | 0.492301 |
| concomitantly administered drugs | 0.486833 |
| depression management | 0.497623 |
| cancer information summary | 0.503433 |
| potentially active ingredients | 0.480985 |
| PDQ summaries | 0.45939 |
| St. John | 0.975444 |
| cancer patients | 0.494368 |
| NCI Fact | 0.496884 |
| wort | 0.678406 |
| effects | 0.47211 |
| complementary therapies | 0.460635 |
| cancer survivors | 0.459401 |
| PDQ summary section | 0.501629 |
| human immunodeficiency virus | 0.480593 |
| various metabolic enzymes | 0.481932 |
| major active constituents | 0.486518 |
| commonly treated symptoms | 0.485606 |
|
| Chinese medical therapies | 0.495937 |
| antidepressant therapy | 0.478022 |
| deep breathing exercises. | 0.492057 |
| Complementary medicine | 0.467053 |
| CAM therapies | 0.48574 |
| specific PDQ summary | 0.501712 |
| dietary supplements | 0.496339 |
| systemic concentrations | 0.461386 |
| alternative medicine | 0.659692 |
| herbal agent | 0.488319 |
| natural killer cell | 0.486571 |
| lower concentrations | 0.45956 |
| traditional Chinese medicine | 0.494167 |
| clinically important effect | 0.485748 |
| monoamine oxidase inhibitor | 0.490216 |
| PDQ summary | 0.540549 |
| randomized controlled trials. | 0.478417 |
| popular herbal agent | 0.484348 |
| NCI Fact Sheet | 0.49194 |
| major depressive disorder | 0.543366 |
| Alternative Medicine website | 0.499408 |
| sufficient concentrations | 0.46476 |
| milder depression | 0.458918 |
| cancer | 0.510149 |
|
CLICK HERE |
| 1908 |
National Cancer Institute |
Html |
es |
Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos. |
| linfocÃtica aguda | 0.505572 |
| leucemia promielocÃtica aguda | 0.536157 |
| siguientes procedimientos | 0.505247 |
| células madre | 0.703397 |
| leucemia mielógena aguda | 0.512482 |
| posibles factores | 0.501447 |
| siguientes aspectos | 0.5019 |
| leucemia aguda | 0.511873 |
| radiación quizás | 0.505162 |
| leucemia linfoblástica aguda | 0.535526 |
| LMA quizás | 0.505703 |
| hueso compacto | 0.505434 |
| neoplasias mieloides | 0.501631 |
| rayos x | 0.501258 |
| enlace drugs approved | 0.505977 |
| Acute Myeloid Leukemia | 0.506164 |
| célula madre mieloide | 0.516071 |
| cáncer.ampliar aspiración | 0.501565 |
| lÃquido cefalorraquÃdeo | 0.511938 |
|
| punción espinal.Ampliar | 0.501523 |
| National Cancer Institute | 0.501258 |
| leucemia granulocÃtica aguda | 0.512402 |
| Instituto Nacional | 0.502137 |
| célula madre linfoide | 0.510737 |
| PDQ Tratamiento | 0.503456 |
| sustancia quÃmica benceno | 0.502803 |
| leucemia mielógena | 0.513696 |
| médula espinal.ampliar quimioterapia | 0.50588 |
| leucemia mieloblástica aguda | 0.512403 |
| sistema nervioso central | 0.50789 |
| Physician Data Query | 0.504454 |
| madre mieloides | 0.518606 |
| siguientes situaciones | 0.504197 |
| células madre mieloides | 0.508803 |
| leucemia mieloide aguda | 0.995372 |
| célula madre | 0.532153 |
| blastocito mieloide | 0.505386 |
| siguientes sumarios | 0.503116 |
|
CLICK HERE |
| 1933 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de cáncer de seno (mama) en el embarazo. |
| estadio lllC | 0.545921 |
| procedimientos quizás | 0.519027 |
| estadio iv | 0.622294 |
| siguientes aspectos | 0.528664 |
| secciones llamadas lóbulos | 0.542754 |
| estadio lllB | 0.547235 |
| estadio lllA | 0.548629 |
| estadios ia | 0.51696 |
| ganglio linfático centinela | 0.983407 |
| Oncotype DX | 0.522717 |
| rayos x | 0.518956 |
| estadio ib | 0.594193 |
| prueba ayuda | 0.551927 |
| estadio ia | 0.593122 |
| pezón afección | 0.529911 |
| enlace drugs approved | 0.522117 |
| mama.ampliar cirugÃa | 0.515861 |
| causó hinchazón | 0.517244 |
| National Cancer Institute | 0.51629 |
| cuántos genes | 0.520169 |
|
| siguientes riesgos | 0.513473 |
| realidad células | 0.541214 |
| Instituto Nacional | 0.528985 |
| cuáles lesiones | 0.51826 |
| estadio iiia | 0.547361 |
| PDQ Tratamiento | 0.523188 |
| estadio iiic | 0.745067 |
| cáncer.ampliar mamografÃa | 0.525478 |
| estadio iia | 0.550898 |
| estadio llB | 0.548944 |
| estadio llA | 0.550289 |
| cuánta proteÃna | 0.522295 |
| siguientes casos | 0.520535 |
| Physician Data Query | 0.558856 |
| carcinoma lobulillar | 0.602006 |
| siguientes partes | 0.548502 |
| Breast Cancer | 0.511799 |
| mamas.ampliar carcinoma lobulillar | 0.536157 |
| siguientes pruebas | 0.564002 |
| vasos sanguÃneos | 0.630183 |
|
CLICK HERE |
| 2987 |
National Cancer Institute |
Html |
en |
Secondhand Smoke |
When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly. |
| feet | 0.409991 |
| dangers | 0.420271 |
| Lung cancer | 0.428942 |
| good example | 0.428021 |
| non-smoker | 0.407426 |
| care staff | 0.426607 |
| nicotine affect | 0.427281 |
| babysitters | 0.406286 |
| body | 0.411562 |
| smoker | 0.414092 |
| children | 0.431937 |
| harms | 0.407652 |
| sure caretakers | 0.428123 |
| secondhand smoke | 0.971613 |
| non-smokers | 0.43912 |
| heart disease‚ | 0.429635 |
| Fact | 0.410452 |
| short time | 0.429909 |
| somebody | 0.406088 |
| health problems | 0.428728 |
| smokefree restaurants | 0.432863 |
| lung infections | 0.428228 |
| smoking indoors | 0.445671 |
| main way smoking | 0.477206 |
| Breathing problems | 0.428866 |
|
| indoor public places | 0.450365 |
| babies | 0.424287 |
| smokers | 0.419121 |
| air | 0.417572 |
| life | 0.412446 |
| Breathing secondhand smoke | 0.5983 |
| infant death syndrome | 0.453829 |
| smoking | 0.508887 |
| National Cancer Institute | 0.448359 |
| heart attack‚ | 0.429618 |
| kids | 0.411336 |
| quiz | 0.411311 |
| cigarette | 0.405834 |
| coughing‚ extra phlegm‚ | 0.454984 |
| bronchitis | 0.405901 |
| people | 0.432125 |
| home | 0.416331 |
| nannies | 0.405803 |
| severe attacks | 0.428972 |
| best thing | 0.428251 |
| shortness | 0.406847 |
| ear infections | 0.428442 |
| low birth weight | 0.454001 |
| family | 0.425482 |
|
CLICK HERE |
| 3528 |
National Cancer Institute |
Html |
es |
Dosis altas de vitamina C (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos sobre el uso de dosis altas de vitamina C como tratamiento para personas con cáncer. |
| Natl Acad Sci | 0.417663 |
| ascorbic acid with | 0.319941 |
| Toxicol In Vitro | 0.313376 |
| Sin embargo | 0.355085 |
| exhibit antitumoral effects | 0.313224 |
| Pauling L | 0.325518 |
| Vitamin C | 0.326615 |
| vitamina c | 0.479277 |
| ascorbate enhanced chemosensitivity | 0.326919 |
| Instituto Nacional | 0.312833 |
| Cancer Res | 0.390148 |
| Chen Q | 0.342148 |
| patients with advanced | 0.354811 |
| supportive treatment | 0.331337 |
| Pharmacologic concentrations | 0.313247 |
| In vitro screening | 0.313326 |
| Med Oncol | 0.314224 |
| acid combination therapy | 0.340469 |
| with ascorbic acid | 0.337638 |
| Padayatty SJ | 0.360813 |
| Levine M | 0.40315 |
| patients with | 0.414812 |
| administración iv | 0.317377 |
| ascorbic acid | 0.947894 |
| estadio iv | 0.317436 |
|
| Pharmacologic doses | 0.312587 |
| voluntarios sanos | 0.317063 |
| intravenous ascorbic acid | 0.330687 |
| Proc Natl Acad | 0.418979 |
| benefit patients with | 0.32288 |
| Biol Blood Marrow | 0.314132 |
| acid therapy | 0.32123 |
| relapsed or refractory | 0.319928 |
| Nutr Cancer | 0.315186 |
| parenteral ascorbate enhanced | 0.327964 |
| National Cancer Institute | 0.323649 |
| ácido ascórbico iv | 0.317065 |
| Transl Med | 0.334599 |
| Intern Med | 0.343771 |
| Chemother Pharmacol | 0.319656 |
| Espey MG | 0.344722 |
| Sun AY | 0.318432 |
| Moertel CG | 0.319183 |
| Chem Biol Interact | 0.340687 |
| phase ii | 0.326203 |
| in vitro | 0.345448 |
| high-dose vitamin | 0.327502 |
| High-dose parenteral ascorbate | 0.330109 |
| ascorbic acid induces | 0.316289 |
|
CLICK HERE |
| 3889 |
National Cancer Institute |
Html |
en |
Parents Who Have a Child with Cancer |
Practical information for parents, when a child has cancer. Tips to help kids and parents cope and stay strong, together with answers to commonly asked questions from parents and children. |
| questions | 0.35493 |
| child life specialist | 0.386505 |
| child’s treatment | 0.35347 |
| child stay | 0.349619 |
| professional help | 0.33179 |
| health care team | 0.725323 |
| integrative medicine | 0.336877 |
| School-aged children | 0.334822 |
| illness children | 0.331523 |
| children | 0.600994 |
| social worker | 0.38279 |
| young children | 0.353967 |
| talk | 0.366273 |
| guide | 0.345294 |
| social media site | 0.334677 |
| individualized education plan | 0.336753 |
| Older children | 0.332601 |
| Child Fights | 0.345493 |
| child’s diagnosis | 0.353024 |
| child react | 0.353407 |
| physical changes | 0.337307 |
| friends | 0.368904 |
| child | 0.906189 |
| parents | 0.404038 |
| treatment | 0.408118 |
|
| Childhood Cancer section | 0.347255 |
| emotional changes | 0.3435 |
| mental health specialist | 0.336601 |
| Children’s Hospital | 0.33095 |
| Stay Strong section | 0.335513 |
| ways | 0.385896 |
| Integrative medicine practices | 0.335837 |
| hospital | 0.356973 |
| social media | 0.340134 |
| people | 0.356129 |
| primary care doctor | 0.338718 |
| way | 0.329858 |
| doctor | 0.358256 |
| child play | 0.355719 |
| school your child | 0.347225 |
| social media sites | 0.338017 |
| new medical information | 0.336758 |
| cancer | 0.500444 |
| information | 0.37152 |
| suggestions | 0.340134 |
| time | 0.433424 |
| family | 0.348424 |
| difficult time | 0.340015 |
| medical situation | 0.335063 |
|
CLICK HERE |
| 16256 |
National Cancer Institute |
Html |
en |
Áreas de investigación |
Sostener un progreso contra el cáncer requiere que se avance a través del continuo de investigación. Entérese de lo extenso que es el trabajo del NCI y de los programas que apoya el instituto para hacer avanzar la investigación oncológica. |
| National Cancer Institute | 0.966549 |
|
|
CLICK HERE |
| 16681 |
National Cancer Institute |
Html |
en |
Cancer Moonshot℠ Blue Ribbon Panel Members |
Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science. |
| Walton Endowed Chair | 0.567818 |
| Cancer Genome Computational | 0.597352 |
| National Cancer Advisory | 0.650925 |
| cancer advocacy groups | 0.631303 |
| Integrative Cancer Research | 0.659981 |
| Cancer Disparities Program | 0.610947 |
| C. Zamecnik Chair | 0.57469 |
| Senior Vice President | 0.528963 |
| Harvard Medical School | 0.539573 |
| Chief Executive Officer | 0.838453 |
| Moores Cancer Center | 0.633784 |
| Cancer Center | 0.989395 |
| Principal Deputy Director | 0.559096 |
| Kimmel Cancer Center | 0.636717 |
| MGH Cancer Center | 0.643509 |
| Associate Professor | 0.561481 |
| Texas MD Anderson | 0.619653 |
| Scott Cancer Center | 0.628322 |
| Hopkins University School | 0.586476 |
| Lurie Comprehensive Cancer | 0.604578 |
| National Brain Tumor | 0.535602 |
| Alumni Distinguished Professor | 0.55884 |
| cancer health disparities | 0.665713 |
| Thomas Jefferson University | 0.541957 |
| cancer prevention | 0.57231 |
|
| Lineberger Comprehensive Cancer | 0.60209 |
| Huntsman Cancer Institute | 0.643082 |
| Ph.D | 0.602332 |
| Anderson Cancer Center | 0.720144 |
| Dana-Farber Cancer Institute | 0.630726 |
| Louisiana State University | 0.545794 |
| Pfizer Worldwide Research | 0.555824 |
| National Cancer Institute | 0.714187 |
| Cancer Research | 0.712054 |
| Sidney Kimmel | 0.530896 |
| Hospital Cancer Center | 0.648303 |
| Blue Ribbon Panel | 0.726957 |
| M.D | 0.540388 |
| Executive Vice President | 0.545293 |
| MD Anderson Cancer | 0.692003 |
| Ludwig Cancer Research | 0.634757 |
| Clinical Cancer Care | 0.584227 |
| Comprehensive Cancer Center | 0.832766 |
| Clausen Distinguished Professor | 0.578861 |
| Cancer Survivorship | 0.543835 |
| Kimmel Comprehensive Cancer | 0.643464 |
| Vanderbilt-Ingram Cancer Center | 0.63051 |
| University Feinberg School | 0.566744 |
| Deputy Director | 0.630447 |
|
CLICK HERE |